EUVIMEDEUVIMED entdecken
Crossref

Public Health Impact of Adjuvanted RSVPreF3 Vaccination Among US Adults Aged ≥60 Years Residing in Long-Term Care Settings

Elizabeth M La, Jonathan Graham, Mei Grace, Eleftherios Zarkadoulas, Neha Shah

Journal of the American Medical Directors Association · 2026-11 · 27 (11) · 106406

DOI: 10.1016/j.jamda.2026.106406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Medical Directors Association, 2026-11. Verfasst von Elizabeth M La und 4 weiteren Autor:innen. Beteiligte Einrichtung: GSK, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines, Public Health, Nursing Homes. Die Arbeit nennt 24 Literaturangaben. Gefördert von: GlaxoSmithKline.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesPublic HealthNursing HomesHumansUnited StatesMaleFemaleMiddle AgedAgedLong-Term CareNursing Home ResidentsAged, 80 and overAdjuvants, ImmunologicMarkov Chains

Stichwörter der Autor:innen

Respiratory syncytial virusUSgeriatric carenursing homevaccination

Substanzen

Respiratory Syncytial Virus VaccinesAdjuvants, Immunologic

Autor:innen und Institutionen

  • GSK, Philadelphia, PA, USA.
  • RTI Health Solutions, LLC, Research Triangle Park, NC, USA.
  • GSK, Wavre, Belgium. Electronic address: eleftherios.x.zarkadoulas@gsk.com.
  • GSK, Houston, TX, USA.

Förderung

  • GlaxoSmithKline

Zitieren

APA

La, E. M., Graham, J., Grace, M., Zarkadoulas, E., & Shah, N. (2026). Public Health Impact of Adjuvanted RSVPreF3 Vaccination Among US Adults Aged ≥60 Years Residing in Long-Term Care Settings. Journal of the American Medical Directors Association, 27(11), 106406. https://doi.org/10.1016/j.jamda.2026.106406

Vancouver

La EM, Graham J, Grace M, Zarkadoulas E, Shah N. Public Health Impact of Adjuvanted RSVPreF3 Vaccination Among US Adults Aged ≥60 Years Residing in Long-Term Care Settings. Journal of the American Medical Directors Association. 2026;27(11):106406. doi:10.1016/j.jamda.2026.106406

BibTeX
@article{La2026,
  author = {La, Elizabeth M and Graham, Jonathan and Grace, Mei and Zarkadoulas, Eleftherios and Shah, Neha},
  title = {Public Health Impact of Adjuvanted RSVPreF3 Vaccination Among US Adults Aged ≥60 Years Residing in Long-Term Care Settings},
  journal = {Journal of the American Medical Directors Association},
  year = {2026},
  volume = {27},
  number = {11},
  pages = {106406},
  doi = {10.1016/j.jamda.2026.106406}
}
Kostenlos starten →